Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/12/16 → 1/12/17 |
Collaborative partners
- Department of Internal Medicine I, Salzburger Landeskliniken (lead)
- Institute of Pathology, Salzburger Landeskliniken
Research output
- 1 Original Article
-
The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics.
Beyreis, M. (First author), Gaisberger, M. (Co-author), Jakab, M. (Co-author), Neureiter, D. (Co-author), Helm, K. (Co-author), Ritter, M. (Co-author), Kiesslich, T. (Co-author) & Mayr, C. R. (Last author), 2019, In: Cancers. 11, 3Research output: Contribution to journal › Original Article › peer-review
19 Citations (Web of Science)